Improved Renal Function of an Everolimus/Enteric-Coated Mycophenolate Sodium Regimen after Calcineurin Inhibitor Withdrawal in de Novo Renal Transplant Patients: 4 Years Follow-Up of the ZEUS Trial

被引：0
|
作者：
Witzke, O. [1 ]
Lehner, F. [2 ]
Arns, W. [3 ]
Reinke, P. [4 ]
Eisenberger, U. [5 ]
Paulus, E. -M [6 ]
May, C. [6 ]
Budde, K. [7 ]
Sommerer, C. [8 ]
机构：
[1] Univ Klinikum Essen, Klin Nieren & Hochdruckkrankheiten, NTx Ambulanz, Essen, Germany
[2] Hannover Med Sch, Klin Allgemein Viszeral & Transplantat Chirurg, Hannover, Germany
[3] Stadt Kliniken Merheim, Univ Klin Koln, Med Klin 1, Transplantat Zentrum, Cologne, Germany
[4] Univ Med Charite Berlin Campus, Med Klin Schwerpunkt Nephrol & Internist Intens M, Berlin, Germany
[5] Univ Spital Bern, Klin & Poliklin Nephrol & Hypertonie, Bern, Switzerland
[6] Novartis Pharmaceut, Nurnberg, Germany
[7] Univ Klinikum Charite Berlin, Med Klin Schwerpunkt Nephrol, Berlin, Germany
[8] Univ Klinikum Heidelberg, Nierenzentrum Heidelberg, Heidelberg, Germany
来源：
TRANSPLANTATION | 2012年 / 94卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
1671
引用
收藏
页码：993 / 993
页数：1
相关论文
共 50 条
  • [1] Improved Renal Function of an Everolimus/Enteric-Coated Mycophenolate Sodium Regimen after Calcineurin Inhibitor Withdrawal in De Novo Renal Transplant Patients: 2 Years Follow-Up of the ZEUS Trial
    Budde, K.
    Arns, W.
    Sommerer, C.
    Reinke, P.
    Eisenberger, U.
    Fischer, W.
    Kramer, S.
    Pietruck, F.
    Becker, T.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 503 - 503
  • [2] Improved Renal Function of an Everolimus/Enteric-Coated Mycophenolate Sodium Regimen after Calcineurin Inhibitor Withdrawal in De Novo Renal Transplant Patients: 5 Years Follow-Up of the ZEUS Trial
    Budde, K.
    Witzke, O.
    Sommerer, C.
    Reinke, P.
    Eisenberger, U.
    Paulus, E.
    Porstner, M.
    May, C.
    Arns, W.
    Lehner, F.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 35 - 36
  • [3] Improved Renal Function of an Everolimus/Enteric-Coated Mycophenolate Sodium Regimen after Calcineurin Inhibitor Withdrawal in De Novo Renal Transplant Patients: 3 Years Follow-Up of the ZEUS Trial
    Budde, K.
    Arns, W.
    Sommerer, C.
    Reinke, P.
    Eisenberger, U.
    Vogel, E. -M.
    Kramer, S.
    Witzke, O.
    Becker, T.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 66 - 66
  • [4] Improved Renal Function of an Everolimus/Enteric-Coated Mycophenolate Sodium Regimen after Calcineurin Inhibitor Withdrawal in De Novo Renal Transplant Patients: 4 Years Follow-Up of the ZEUS Trial.
    Budde, K.
    Lehner, F.
    Arns, W.
    Reinke, P.
    Eisenberger, U.
    Paulus, E. -M.
    May, C.
    Sommerer, C.
    Witzke, O.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 298 - 298
  • [5] 5 YEARS FOLLOW-UP ON RENAL FUNCTION - ZEUS TRIAL: IMPROVED RENAL FUNCTION OF AN EVEROLIMUS/ENTERIC-COATED MYCOPHENOLATE SODIUM REGIMEN AFTER CALCINEURIN INHIBITOR WITHDRAWAL IN DE NOVO RENAL TRANSPLANT PATIENTS
    Reinke, P.
    Lehner, F.
    Witzke, O.
    Sommerer, C.
    Eisenberger, U.
    Arns, W.
    Porstner, M.
    May, C.
    Paulus, E. -M.
    Budde, K.
    [J]. TRANSPLANT INTERNATIONAL, 2013, 26 : 21 - 21
  • [6] IMPROVED RENAL FUNCTION OF AN EVEROLIMUS/ENTERIC-COATED MYCOPHENOLATE SODIUM REGIMEN AFTER CALCINEURIN INHIBITOR WITHDRAWAL IN DE NOVO RENAL TRANSPLANT PATIENTS: 3 YEAR FOLLOW-UP OF THE ZEUS TRIAL
    Lehner, Frank
    Budde, Klemens
    Arns, Wolfgang
    Sommerer, Claudia
    Reinke, Petra
    Eisenberger, Ute
    Vogel, Eva-Maria
    Scheidl, Stefan
    Witzke, Oliver
    [J]. TRANSPLANT INTERNATIONAL, 2011, 24 : 57 - 57
  • [7] THREE YEARS FOLLOW-UP OF THE ZEUS TRIAL: MAINTAINED BETTER RENAL FUNCTION OF AN EVEROLIMUS/ENTERIC-COATED MYCOPHENOLATE SODIUM REGIMEN AFTER CALCINEURIN INHIBITOR WITHDRAWAL IN DE NOVO RENAL TRANSPLANT PATIENTS
    Lehner, F.
    Arns, W.
    Witzke, O.
    Budde, K.
    Sommerer, C.
    Eisenberger, U.
    Paulus, E. -M.
    Scheidl, S.
    Reinke, P.
    [J]. TRANSPLANT INTERNATIONAL, 2011, 24 : 50 - 50
  • [8] CONVERSION TO AN EVEROLIMUS/ENTERIC-COATED MYCOPHENOLATE SODIUM REGIMEN AFTER CALCINEURIN INHIBITOR WITHDRAWAL IN DE NOVO RENAL TRANSPLANT PATIENTS IMPROVES RENAL FUNCTION: 2 YEARS FOLLOW-UP OF THE ZEUS TRIAL
    Sommerer, C.
    Becker, T.
    Budde, K.
    Pietruck, F.
    Eisenberger, U.
    Fischer, W.
    Kramer, S.
    Reinke, P.
    Arns, W.
    [J]. TRANSPLANT INTERNATIONAL, 2010, 23 : 60 - 60
  • [9] Efficacy and Safety of an Everolimus/Enteric-Coated Mycophenolate Sodium Regimen after Calcineurin Inhibitor Withdrawal in De Novo Renal Transplant Patients: Results of the ZEUS Trial
    Pietruck, F.
    Becker, T.
    Arns, W.
    Sommerer, C.
    Reinke, P.
    Eisenberger, U.
    Fischer, W.
    Kramer, S.
    Budde, K.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 499 - 499
  • [10] RENAL FUNCTION IN EVEROLIMUS/ENTERIC-COATED MYCOPHENOLATE SODIUM TREATED DE NOVO RENAL TRANSPLANT RECIPIENTS AFTER CALCINEURIN INHIBITOR WITHDRAWAL: THE ZEUS STUDY
    Becker, T.
    Arns, W.
    Budde, K.
    Eisenberger, U.
    Fischer, W.
    Kramer, S.
    Reinke, P.
    Sommerer, C.
    Pietruck, F.
    [J]. TRANSPLANT INTERNATIONAL, 2009, 22 : 78 - 79
12345